As we observed indications of attenuated NAFLD development in the HFD-fed Tlcd1/2 DKO mice compared to controls, we hypothesized that Tlcd1/2 deletion may also be protective against NASH in mice. Here, TLCD1 is linked to metabolic dysfunction-associated steatohepatitis.